What is the significance of an isolated elevated activated partial thromboplastin time in the preoperative setting?

Cleveland Clinic Journal of Medicine

Volumn 74, Issue ELECTRONICSUPPL.1, 2007, Pages

  Morris, William H ^a   Kumar, Ajay ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BLEEDING; BLOOD; HUMAN; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; PREOPERATIVE CARE; REVIEW; RISK;

BIOLOGICAL MARKERS; HEMORRHAGE; HUMANS; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RISK;

EID: 42949140926     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.74.Electronic_Suppl_1.S13     Document Type: Article

References (6)

1. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost 2005; 3:2607-2611.
2. Chee Y-L, Greaves M. Role of coagulation testing in predicting bleeding risk. Hematol J 2003; 4:373-378.
3. Krishna P, Lee D. Post-tonsillectomy bleeding: a meta-analysis. Laryngoscope 2001; 111:1358-1361.
4. Suchman AL, Mushlin AI. How well does the activated partial thromboplastin time predict postoperative hemorrhage? JAMA 1986; 256:750-753.
5. Kitchens CS. Prolonged activated partial thromboplastin time of unknown etiology: a prospective study of 100 consecutive cases referred for consultation. Am J Hematol 1988; 27:38-45.
6. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 74:1185-1190.